Merck's Deal For Terns And Its Stellar CML Drug Candidate Looks Like Good Business
Corroborated by 1 source from 1 publisher
globalhealth5h ago
TL;DR
According to seekingalpha.com, investment Overview Today, news has broken that Terns Pharmaceuticals, Inc.